Resources
Related Tags:
Albany Molecular Research Inc. (10 results)
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Albany Molecular Research, Inc. Announces Fourth Quarter, Full Year 2005 Results; Posts Full Year Contract Revenue Growth of 13%
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (Nasdaq: AMRI) today reported financial results for the quarter and year ending December 31, 2005.
- Research articles 2006-02-13
Additional Resources
- Albany Molecular Research, Inc. Rebrands to AMRI, Unveils New Corporate Identity
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (NASDAQ: AMRI), with multiple locations in the United States, Europe and Asia, announced today that it has changed its brand name to "AMRI". As a result, Albany Molecular Research, Inc. is now conducting its business throughout the world as "AMRI".
- Research articles 2007-05-01
- AMRI to Receive Second Milestone Payment from Licensing Agreement with Bristol-Myers Squibb
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today it will receive a $4 million milestone payment from Bristol-Myers Squibb Company (NYSE: BMY) as a result of Bristol-Myers Squibb's submission of a Clinical Trial Application CTA to the Health Products and Food Branch HPFB, Health Canada for approval to initiate Phase...
- Research articles 2008-06-12
- AMRI Announces Long-Term Manufacturing Agreement with New River Pharmaceuticals
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (Nasdaq: AMRI) today announced a multi-year drug substance manufacturing agreement with New River Pharmaceuticals Inc. (Nasdaq: NRPH). Financial terms were not disclosed. Under the agreement, AMRI will manufacture the active pharmaceutical ingredient in New River's compound, NRP104, a new treatment for attention...
- Research articles 2006-07-24
- AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration
- To: BUSINESS EDITORSContact: Laurie Fink, Director of Media Relations of Cystic Fibrosis Foundation, +1-301-841-2602, lfink@cff.org; or Thai Phi Stone, +1-301-907-2593, tpstone@cff.org; or David Albert, Director of Communications of AMRI, +1-518-512-2229 ANAHEIM, Calif. and ALBANY, N.Y., Oct. 4 /PRNewswire-USNewswire/ - - AMRI (Nasdaq: AMRI) and the Cystic Fibrosis Foundation Therapeutics, Inc....
- Research articles 2007-10-04
- AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration
- Total Value Could Reach Up to $23.7 Million ANAHEIM, Calif. & ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) and Cystic Fibrosis Foundation Therapeutics, Inc. CFFT, the nonprofit affiliate of the Cystic Fibrosis Foundation, announced today a four-year research collaboration worth up to $23.7 million, aimed at identifying novel treatments that...
- Research articles 2007-10-04
- AMRI Names New Chemistry Director at Its European Site
- BUDAPEST, Hungary -- AMRI (NASDAQ: AMRI) has named Dr. Philip William Small as director of chemistry at its Hungarian site. In his new position, Dr. Small will assume responsibilities for all of AMRI's European chemistry related activities including custom synthesis, medicinal chemistry, analytical services, library design and production. ...
- Research articles 2007-11-28
- AMRI Invests in Organichem.(Brief Article)
- ALBANY MOLECULAR Research Inc. AMRI is investing in Organichem Corporation, a new contract manufacturing entity formed by the management of Nycomed Amersham PLC. Simultaneously, Organichem has closed its agreement to purchase Nycomed's chemical m ALBANY MOLECULAR Research Inc. AMRI is investing in Organichem ...
- Research articles 1999-12-27
- AMRI signs research pact with Lilly. (Breaking News Roundup).(Albany Molecular Research Inc., US)(Brief Article)
- Albany Molecular Research Inc. AMRI has entered into a three-year natural products research collaboration with Eli Lilly and Company for the discovery and development of potential therapeutic agents for diseases of interest to both companies. Und Albany Molecular Research Inc. AMRI has entered into...
- Research articles 2003-02-17
- AMRI and Bristol-Myers form, new joint venture. (Breaking News Roundup).(Albany Molecular Research Inc. gets contract from Bristol-Myers Squibb Co.)(Brief Article)
- Albany Molecular Research Inc. AMRI has replaced its contract with the former DuPont Pharmaceuticals Company, which was acquired by BristolMyers Squibb Company BMS in October 2001, with a new three-year multimillion dollar agreement between AMR Albany Molecular Research Inc. AMRI has replaced its contract...
- Research articles 2002-02-25
- AMRI Receives Milestone Payment From Licensing Agreement with Bristol-Myers Squibb
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (NASDAQ: AMRI) announced today that a compound being developed under its license and research agreement with Bristol-Myers Squibb Company (NYSE: BMY) will proceed into preclinical development, triggering a $1.5 million payment to AMRI. This marks the first milestone in the ongoing research collaboration...
- Research articles 2007-06-11
- AMRI CEO Donates Stock to Rensselaer Polytechnic Institute
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (Nasdaq: AMRI) announced today that Thomas and Constance D'Ambra have made a personal gift of 85,000 shares of AMRI stock to Rensselaer Polytechnic Institute. The donation is a second installment to honor a $3 million commitment made by the D'Ambras to endow a...
- Research articles 2005-12-22
- AMRI to Present at the Wachovia 2008 Healthcare Conference
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the Wachovia 2008 Healthcare Conference on Wednesday, January 30th at the Langham Hotel in Boston, Massachusetts.
- Research articles 2008-01-24
- AMRI to Present at the 2008 JPMorgan Healthcare Conference
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it will present at the 2008 JPMorgan Healthcare Conference on Thursday, January 10th at the Westin St. Francis Hotel in San Francisco, CA.
- Research articles 2008-01-07
- AMRI to Present at Bank of America 2008 Smid Cap Conference
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the Bank of America 2008 Smid Cap Conference on Wednesday, March 26, 2008.
- Research articles 2008-03-25
- AMRI to Present at Bank of America 2008 Healthcare Conference
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the Bank of America 2008 Healthcare Conference on Wednesday, May 14, 2008.
- Research articles 2008-05-09
- AMRI CEO Donates Stock to Rensselaer Polytechnic Institute
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (NASDAQ: AMRI) announced today that Thomas and Constance D'Ambra have made a personal gift of 75,000 shares of AMRI stock to Rensselaer Polytechnic Institute RPI. The donation is the third and final installment to honor a $3 million commitment made by the D'Ambras...
- Research articles 2006-12-22
- AMRI to Present at the UBS 2007 Global Life Sciences Conference
- ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) will present at the UBS 2007 Global Life Sciences Conference on Tuesday, September 25th at the Grand Hyatt, Park Avenue at Grand Central Terminal in New York City.
- Research articles 2007-09-20
- InvestSource Coverage Alerts: AMJL, IDCC, AVE AMRI, SNTK.
- M2 PRESSWIRE-10 March 2004-InvestSource Inc.: InvestSource Coverage Alerts: AMJL, IDCC, AVE AMRI, SNTKC1994-2004 M2 COMMUNICATIONS LTD RDATE:03102004 Amigula Incorporated (OTC: AMJL), InterDigital Communications Corporation (Nasdaq: IDCC), Aventis SA (NYSE: AVE), Albany Molecular Research Incorporated (Nasdaq: AMRI), and Senetek PLC (Nasdaq: SNTK)....
- Research articles 2004-03-10
- AMRI Agrees to New Contract with International Chemical Workers Union
- ALBANY, N.Y. -- Albany Molecular Research, Inc. (NASDAQ: AMRI) has agreed to a new four-year contract with the International Chemical Workers Union Council of the United Food and Commercial Workers Union Local 61-C. The contract covers chemical operators and maintenance technicians at AMRI's large scale manufacturing facility in Rensselaer, New...
- Research articles 2007-01-18
- << Previous
- page 1 of 1
- Next >>
